IRCT20140120016280N6招募中1 期
Comparative study of the combined effect of temozolomide with nilotinib and temozolomide alone on non-surgical newly diagnosed human glioblastoma multiform tumor: A phase I-II, controlled, placebo, randomized, triple-blinded clinical trial
ational Institute for Medical Research Development (NIMAD)0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age of 18 years and more
- •Has newly diagnosis of GBM as determined by MRI findings.
- •Tumors of deep and non-surgical areas
- •Candidate for non-surgical treatment or biopsy
排除标准
- •Age under 18 years
- •Breastfeeding
- •Hepatic or renal dysfunction
- •Concomitant with other brain diseases
- •Existence of metastasis
- •Psychosis and cognitive impairment
- •Autoimmune diseases
- •Patients undergoing brain surgery
- •Ischemic heart disease
- •Receiving other chemotherapy drugs or immunosuppressants during the last three months
研究者
相似试验
招募中
3 期
Comparison of the effect of minoxidil and spironolactone with minoxidil and finasteride in the treatment of Androgenic AlopeciaIRCT20211210053343N1Iran University of Medical Sciences60
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-DEEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-GBEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
1 期
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMMedDRA version: 7.1Level: PTClassification code 10018337Glioblastoma multiformeEUCTR2004-003896-35-ATEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-BEEuropean Organisation for Research and Treatment of Cancer220